Cargando…

Preliminary Study on the Expression and the Clinical Significance of CD133 in Peripheral Blood of Patients with Gastric Adenocarcinoma

Background. Significances of CD133 mRNA in peripheral blood mononuclear cells (PBMCs) of gastric adenocarcinoma (GC) patients were investigated. Methods. Correlations of CD133 mRNA expression in PBMCs on clinicopathological parameters or CD133 protein expression were analyzed. Receiver operating cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ju-gang, Yu, Ji-wei, Lu, Rui-qi, Wang, Shou-lian, Ni, Xiao-chun, Zheng, Lin-hai, Jiang, Bo-jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932643/ https://www.ncbi.nlm.nih.gov/pubmed/24653835 http://dx.doi.org/10.1155/2014/245329

Ejemplares similares

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Study on the Biological Characteristics of CD133(+) Cells Interfered by RNA Interference in Gastric Cancer
por: Yu, Ji-wei, et al.
Publicado: (2014)

CD133 expression in different stages of gastric adenocarcinoma
por: Boegl, M, et al.
Publicado: (2009)

Transcatheter Arterial Infusion of Autologous CD133(+) Cells for Diabetic Peripheral Artery Disease
por: Zhang, Xiaoping, et al.
Publicado: (2016)

Reply: CD133 expression in different stages of gastric adenocarcinoma
por: Smith, L M, et al.
Publicado: (2009)

Expression and Significances of Contactin-1 in Human Gastric Cancer
por: Yu, Ji-Wei, et al.
Publicado: (2013)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Influencing factors and clinical significance of the metastatic lymph nodes ratio in gastric adenocarcinoma
por: Yu, Ji-wei, et al.
Publicado: (2009)

Risk Factors and Prognostic Significance of Retropancreatic Lymph Nodes in Gastric Adenocarcinoma
por: Xue, Lian, et al.
Publicado: (2015)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells
por: Lu, Ruiqi, et al.
Publicado: (2019)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Significance of CD133 expression in esophageal squamous cell carcinoma
por: Okamoto, Hiroshi, et al.
Publicado: (2013)

Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
por: Zhao, Po, et al.
Publicado: (2010)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Prognostic significance of KIF23 expression in gastric cancer
por: Liang, Wei-Tian, et al.
Publicado: (2020)

Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet
por: Zheng, Shi-Min, et al.
Publicado: (2022)

Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells
por: Chen, De-Hu, et al.
Publicado: (2015)

Galectin-1 is overexpressed in CD133(+) human lung adenocarcinoma cells and promotes their growth and invasiveness
por: Zhou, Xuefeng, et al.
Publicado: (2014)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
por: Immervoll, Heike, et al.
Publicado: (2008)

DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma
por: Thanan, Raynoo, et al.
Publicado: (2016)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

Prognostic significance of CD133 and ABCB5 expression in papillary thyroid carcinoma
por: Karas Zella, Maria Augusta, et al.
Publicado: (2020)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Prognostic significance of preoperative and postoperative CK19 and CEA mRNA levels in peripheral blood of patients with gastric cardia cancer
por: Qiao, Yu-Feng, et al.
Publicado: (2017)

Aberrant expression of CD133 and CD82 in patients with pediatric acute lymphoblastic leukemia and the clinical significance
por: Ji, Hongyan, et al.
Publicado: (2017)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas
por: Mardani, Azam, et al.
Publicado: (2020)

Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival
por: Zhang, Qingping, et al.
Publicado: (2019)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Flow Cytometric Analysis of CD133- and EpCAM-Positive Cells in the Peripheral Blood of Patients with Lung Cancer
por: Skirecki, Tomasz, et al.
Publicado: (2013)

Prognostic significance of Versican expression in gastric adenocarcinoma
por: Shen, X-H, et al.
Publicado: (2015)

Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis
por: Gong, Weihua, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved
por: Lu, Li, et al.
Publicado: (2016)

Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
por: Hashimoto, Kousuke, et al.
Publicado: (2013)

Expression of CD133 as a cancer stem cell marker in invasive gastric carcinoma
por: Attia, S., et al.
Publicado: (2019)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma
por: Yu, Lan, et al.
Publicado: (2014)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l8i896u0n9qugbkbecnt8rlbqp